Table 1 General information on each PRRSV infection trial
Trial(s) | Genetic line | Breed | Viral load | Weight gain | PRRSV isolate | ||
|---|---|---|---|---|---|---|---|
N | Average (s.d.) | N | Average (s.d.) | ||||
1–3 | 1 | LWa × LRb | 504 | 108.3 (8.1) | 487 | 12.1 (4.4) | NVSL |
4 | 2 | Duroc × LW/LR | 192 | 113.2 (6.3) | 190 | 15.9 (4.0) | |
5 | 3 | Duroc × LR/LW | 184 | 101.4 (7.2) | 183 | 19.1 (2.9) | |
6 | 4 | LR × LR | 123 | 109.6 (8.0) | 106 | 14.8 (5.6) | |
7 | 5 | Pietrain × LW/LR | 189 | 104.5 (6.2) | 189 | 14.5 (3.2) | |
8 | 6 | Duroc × Yc/LR | 188 | 107.9 (6.6) | 182 | 10.2 (4.6) | |
15 | 7 | LR × LW | 171 | 107.6 (10.9) | 165 | 19.1 (4.0) | |
NVSL | Total | – | 1551 | 107.0 (8.4) | 1502 | 14.9 (5.0) | |
10 | 7 | LR × LW | 174 | 93.9 (6.7) | 179 | 19.1 (4.2) | KS06 |
11 | 1 | LW × LR | 170 | 100.4 (6.4) | 178 | 18.6 (4.4) | |
12 | 8 | LR × LW | 171 | 104.7 (6.3) | 170 | 19.0 (4.1) | |
14 | 3 | Duroc × LR/LW | 180 | 98.6 (7.7) | 171 | 21.3 (4.1) | |
KS06 | Total | – | 695 | 99.4 (7.8) | 641 | 19.5 (4.3) | |
Total | – | – | 2246 | 104.6 (8.9) | 2200 | 16.4 (5.2) | – |